Skip to content

Network Analysis of Interoceptive Sensitivity in Symptom Recognition and Management for Lung Cancer Chemotherapy Patients

Network Analysis of Interoceptive Sensitivity in Symptom Recognition and Management for Lung Cancer Chemotherapy Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113250
Enrollment
Unknown
Registered
2025-11-26
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Case group:None

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Hospitalised patients with histologically or cytologically confirmed lung cancer; 2. Receiving their first course of chemotherapy as the sole treatment (undergoing 4–6 standard cycles of chemotherapy at 21–28 day intervals); 3. Willing to participate in the study; 4. Aged >=18 years; 5. Proficient in Chinese with no comprehension difficulties; 6. Willing to participate in this study after providing informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cognitive impairment or psychiatric disorders; 2. Patients with concomitant severe organ dysfunction affecting the heart, brain, kidneys, or other vital organs; 3. Patients unaware of their medical condition; 4. Patients concurrently undergoing radiotherapy and/or surgical treatment.

Design outcomes

Primary

MeasureTime frame
Interoceptive Sensitivity ;MD Anderson Symptom Inventory - Lung Cancer Module (MDASI-LC) ;

Secondary

MeasureTime frame
Cancer Self-Managemen;

Countries

China

Contacts

Public ContactXielihai

Zhejiang Provincial People's Hospital

814192015@qq.com+86 571 8589 3608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026